← Back
$IONS All transactions

IONIS PHARMACEUTICALS INC

▼ SELL 10b5-1 Plan

$ Value

$409K

Shares

9,549

Price

$43

Filed

Aug 5

Insider

Name

Schneider Eugene

Title

EVP, Chf Clinical Develop Ofcr

CIK

0001838539

Roles

Officer

Transaction Details

Transaction Date

2025-08-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

51,507

Footnotes

Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.315 to $43.45 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.

Filing Info

Accession No.

0000874015-25-000172

Form Type

4

Issuer CIK

0000874015

Schneider Eugene's History

Date Ticker Type Value
2025-09-03 IONS M $1.1M
2025-09-03 IONS $753K
2025-09-03 IONS $442K
2025-09-03 IONS M $0
2025-08-04 IONS $409K

Other Insiders at IONS (90d)

Insider Bought Sold Last
PARSHALL B LYNNE $381K 2026-04-15
KLEIN JOSEPH III $1.7M 2026-04-01
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
$368K 2026-04-16
Baroldi Joseph
EVP, Chief Business Officer
$419K 2026-04-16
Birchler Brian
EVP, Corp and Development Ops
$73K 2026-04-16
Devers Shannon L.
EVP, Chief Human Resources Ofc
$459K 2026-04-02